# OnCo record inhatarget-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/inhatarget-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "inhatarget-therapeutics" ;
  schema:name "InhaTarget Therapeutics"@en ;
  schema:description "InhaTarget Therapeutics turns the chemotherapy drug cisplatin into a dry powder that people breathe in, so more of it reaches lung tumours and less reaches the rest of the body. It has been tested alongside standard immunotherapy in advanced non-small cell lung cancer."@en ;
  schema:url <https://onco.cc/companies/inhatarget-therapeutics/>, <https://www.inhatarget.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.inhatarget.com/>, <https://www.inhatarget.com/clinical-trial> ;
  schema:addressCountry "BE" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:trials <https://onco.cc/trials/nct06896890/> .